China Resources Pharmaceutical Group
China Resources Pharmaceutical Group Limited is an integrated pharmaceutical group headquartered in Beijing, China. The company operates across pharmaceutical research and development, manufacturing, wholesale distribution, and retail pharmacy chains. Its product lineup encompasses prescription drugs, over-the-counter medicines, and traditional Chinese medical treatments across multiple therapeutic fields. Revenue is primarily generated through pharmaceutical wholesale distribution networks and product sales to hospitals, clinics, and retail pharmacies. The firm holds a leading market position within the mainland Chinese healthcare and distribution sectors. China Resources Pharmaceutical Group Limited is publicly listed on the Hong Kong Stock Exchange.
6 of the funds FundTelligence covers report a position in China Resources Pharmaceutical Group.
- Legal name
- China Resources Pharmaceutical Group Ltd
- Sector
- Health Care
- Country
- China
- Funds holding it
- 6
Funds holding China Resources Pharmaceutical Group
- KLP AksjeFremvoksende Markeder Flerfaktor — KLP · 0.43 % (full portfolio disclosed, June 2026)
- SEB Emerging Marketsfond — SEB · 0.04 % (full portfolio disclosed, June 2026)
- Storebrand Emerging Markets — Storebrand · 0.02 % (full portfolio disclosed, October 2026)
- SEB Asienfond ex Japan — SEB · 0.02 % (full portfolio disclosed, June 2026)
- BlackRock iShares MSCI EM IMI Screened UCITS ETF — BlackRock · 0.01 % (full portfolio disclosed, October 2026)
- Storebrand Global All Countries — Storebrand · 0.0 % (full portfolio disclosed, October 2026)